New Molecular Recognition Method Aids KRAS Inhibitor Design

Researchers have published new findings on utilizing bridged conformations for precise molecular recognition, which is crucial for designing KRAS inhibitors. This advance in chemical biology and drug design holds potential significance for future cancer research and therapeutic development.